Search Results

Roundtable Discussion: Surveying the Landscape: SFA Drug Delivery Trial Designs and Data

Experts discuss key elements of SFA trials, whether a global algorithmic approach to treating SFA disease is possible, and the limitations of cross-trial platform comparisons.

Moderator: William A. Gray, MD
Panel: Gary M. Ansel, MD; Koen Deloose, MD; Michael R. Jaff, DO; and Peter A. Schneider, MD

Bioresorbable Vascular Scaffolds: Progress and Potential

Koen Deloose, MD, discusses the potential advantages of this technology, results to date, and remaining questions to be answered.

Around the SFA World

By Koen Deloose, MD, Guest Chief Medical Editor, and John R. Laird, MD, Chief Medical Editor

Peripheral Vascular Care: A Clinical and Administrative Perspective

Michael R. Jaff, DO, answers questions posed by Gary M. Ansel, MD, FACC, and Koen Deloose, MD, on the challenges of his new role as hospital president and how new regulatory and reimbursement models might affect vascular care delivery.

With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; and Koen Deloose, MD

Safety in SFA Intervention

By Marianne Brodmann, MD, and John R. Laird Jr, MD

TVR Reduction in the SFA

How do current TVR reduction rates compare with earlier values?

By Koen Deloose, MD; Marc Bosiers, MD; and Joren Callaert, MD

Lesion-Specific SFA Device Selection

Key questions to consider for accurate diagnoses and tailored treatment decisions.

By Koen Deloose, MD

Scoring and Cutting Balloons for SFA Disease Treatment

The role of these devices for percutaneous intervention in this challenging anatomy.

By Marc Bosiers, MD; Koen Deloose, MD; Jurgen Verbist, MD; and Patrick Peeters, MD

Clinical Application of the Xpert Stent

New data show effectiveness in the treatment of critical limb ischemia caused by infrapopliteal lesions.

By Marc Bosiers, MD; Koen Deloose, MD; Jürgen Verbist, MD; and Patrick Peeters, MD

3D Navigation in Complex TEVAR

A case report demonstrating the benefits of a three-dimensional endovascular guiding system.

By Lieven Maene, MD; Roel Beelen, MD; Patrick Peeters, MD; Jürgen Verbist, MD; Koen Keirse, MD; Koen Deloose, MD; Joren Callaert, MD; and Marc Bosiers, MD

Ask the Experts: What Will Dominate the Next Era in SFA Therapy?

Experts discuss the current era of drug-eluting technologies and what might come next.

With Koen Deloose, MD; Craig Walker, MD; and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

How concerned are you regarding radiation exposure over a high volume of challenging SFA cases, and what safety measures has your facility implemented?

With Jos C. van den Berg, MD, PhD; Christopher W. Boyes, MD; Koen Deloose, MD; Larry J. Diaz-Sandoval, MD, FACC, FSCAI; Prof. Dr. Erich Minar; and Thomas P. Davis, MD, FACC

A Time for Refinement in Comprehensive Venous Care

By Stephen A. Black, MD, FRCS (Ed), FEBVS, and Erin H. Murphy, MD, FACS